Steven L Basta's Net Worth
$6.72 Million
Who is Steven L Basta?
Steven L Basta has an estimated net worth of $6.72 Million. This is based on reported shares across multiple companies, which include BIOFORM MEDICAL INC, KalVista Pharmaceuticals, Inc., VYNE Therapeutics Inc., and VIVEVE MEDICAL, INC..
SEC CIK
Steven L Basta's CIK is 0001417397
Past Insider Trading and Trends
2009 was Steven L Basta's most active year for acquiring shares with 4 total transactions. Steven L Basta's most active month to acquire stocks was the month of December. 2010 was Steven L Basta's most active year for disposing of shares, totalling 10 transactions. Steven L Basta's most active month to dispose stocks was the month of January. 2019 saw Steven L Basta paying a total of $25,620.00 for 491,600 shares, this is the most they've acquired in one year. In 2010 Steven L Basta cashed out on 1,995,000 shares for a total of $5,204,750.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOFORM MEDICAL INC No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -955.00K |
$5.45 | -$5,204,750.00 |
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$2.27 | -$72,710.00 | 922.09K |
Scheduled
|
Nov 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$8.22 | -$847.35 |
0
|
Nov 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
VYNE Therapeutics Inc. (VYNE) Snapshot price: $2.12
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4/A
| +48.98% | 167.59K |
$3.18 | -$385,149.20 | 509.76K |
Dec 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
VIVEVE MEDICAL, INC. (VIVE) Snapshot price: $0.0002
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |